Good progress on pancreatic cancer treatment
Israel’s Silexion Therapeutics reported that its SIL-204 pancreatic cancer treatment effectively reduces primary tumor growth and secondary cancer spread. Silexion 's first generation LODER treatment already had good results in Phase 2 trials on “simple” cancers.
From cultivated meat to muscle therapy
Israel’s Profuse (see previously) which specializes in the laboratory cultivation of muscle tissue for non-animal meat, has launched a new technology and program for preventing and restoring muscle lost by the growing use of weight-loss treatments, aging, and cancer.
Rehabilitation conference
Israel hosted the “Lifetime Partnership” International Rehabilitation Conference in Tel Aviv. It attracted medical and rehabilitation experts from militaries, defense ministries, and health departments in England, Thailand, Germany, Hungary, the Czech Republic, Brazil and Canada.
Combining complementary and conventional medicine
Israel’s Treat Me (see ) has developed an AI-driven platform that allows practitioners to create tailor-made treatment plans that bridge Western medicine, complementary therapies (e.g. Chinese medicine, naturopathy, reflexology) and cutting-edge research.
US approves rotator cuff repair system
Israel’s Arcuro Medical (see previously) has received US FDA clearance for its SuperBall-RC system for use in rotator cuff (shoulder) repair procedures. Arcuro's SuperBall technology platform has now successfully been used in over 5,000 meniscus (knee) repairs.
Combatting gum disease and more
Hebrew University of Jerusalem scientists have discovered how the bacteria Porphyromonas gingivalis causes periodontitis infection (gum disease). Preventing it binding to protein CD47 prevents periodontitis, and its correlation with cardiovascular disease, Alzheimer’s, and cancer.
Real-time blood tests
Israel’s Inspira Technologies (see previously) announced positive results from the clinical study at Sheba Hospital of its AI-powered HYLA blood sensor. Its real-time blood monitoring enables early diagnosis and personalized care without the need for intermittent blood draws.
What’s happening inside
Prof Hossam Haick of Israel’s Technion and his team have developed a new method for monitoring molecular processes deep within tissue. Their system uses chemical tomography to analyze volatile organic compounds (VOCs). It can help early cancer detection in many organs of the body.
How cells respond to treatment
Researchers from Tel Aviv University have developed scNET that tracks gene expression at the single-cell level in response to various therapies. It has exciting implications for research into cancer treatments and their effect on the tumor, pro-cancer supporting cells, and anti-cancer immune cells.
New way to treat resistant cancers
Israel’s MitoCarex Bio has developed its MITOLINE™ algorithm and other advanced computational capabilities to identify small molecules that can fight cancer. MitoCarex has just been acquired by Israel’s N2OFF (see previously) which is also injecting $1 million of investment.
`